SE9202968L - Nya peptider, diagnostiska antigener, deras användning, vacciner och medikamenter - Google Patents

Nya peptider, diagnostiska antigener, deras användning, vacciner och medikamenter

Info

Publication number
SE9202968L
SE9202968L SE9202968A SE9202968A SE9202968L SE 9202968 L SE9202968 L SE 9202968L SE 9202968 A SE9202968 A SE 9202968A SE 9202968 A SE9202968 A SE 9202968A SE 9202968 L SE9202968 L SE 9202968L
Authority
SE
Sweden
Prior art keywords
influenza
peptides
virus
antigens
viruses
Prior art date
Application number
SE9202968A
Other languages
English (en)
Other versions
SE9202968D0 (sv
Inventor
S Viazov
J Blomberg
E Isaeva
R Pipkorn
Original Assignee
Replico Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Replico Medical Ab filed Critical Replico Medical Ab
Priority to SE9202968A priority Critical patent/SE9202968L/sv
Publication of SE9202968D0 publication Critical patent/SE9202968D0/sv
Priority to PCT/SE1993/000818 priority patent/WO1994009035A1/en
Priority to AU52891/93A priority patent/AU5289193A/en
Publication of SE9202968L publication Critical patent/SE9202968L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16311—Influenzavirus C, i.e. influenza C virus
    • C12N2760/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SE9202968A 1992-10-09 1992-10-09 Nya peptider, diagnostiska antigener, deras användning, vacciner och medikamenter SE9202968L (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9202968A SE9202968L (sv) 1992-10-09 1992-10-09 Nya peptider, diagnostiska antigener, deras användning, vacciner och medikamenter
PCT/SE1993/000818 WO1994009035A1 (en) 1992-10-09 1993-10-11 New influenza virus peptides, diagnostics and vaccines
AU52891/93A AU5289193A (en) 1992-10-09 1993-10-11 New influenza virus peptides, diagnostics and vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9202968A SE9202968L (sv) 1992-10-09 1992-10-09 Nya peptider, diagnostiska antigener, deras användning, vacciner och medikamenter

Publications (2)

Publication Number Publication Date
SE9202968D0 SE9202968D0 (sv) 1992-10-09
SE9202968L true SE9202968L (sv) 1994-04-10

Family

ID=20387437

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9202968A SE9202968L (sv) 1992-10-09 1992-10-09 Nya peptider, diagnostiska antigener, deras användning, vacciner och medikamenter

Country Status (3)

Country Link
AU (1) AU5289193A (sv)
SE (1) SE9202968L (sv)
WO (1) WO1994009035A1 (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1843158A1 (de) * 2006-04-05 2007-10-10 Micronas Holding GmbH Nachweissystem für Krankheitserreger
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
AU2008293504B2 (en) 2007-08-27 2012-04-12 Longhorn Vaccines & Diagnostics, Llc Immunogenic compositions and methods
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
CA2861667C (en) 2007-10-01 2017-06-13 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system and methods of use
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
WO2013112916A1 (en) 2012-01-26 2013-08-01 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
WO2016183292A1 (en) 2015-05-14 2016-11-17 Longhorn Vaccines And Diagnostics, Llc Rapid methods for the extraction of nucleic acids from biological samples
IL319551A (en) 2018-05-18 2025-05-01 Emergex Vaccines Holding Ltd Peptide reverse vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981782A (en) * 1987-05-14 1991-01-01 Sri International Synthetic peptides for diagnosis and prevention of influenza virus infection and their use

Also Published As

Publication number Publication date
AU5289193A (en) 1994-05-09
WO1994009035A1 (en) 1994-04-28
SE9202968D0 (sv) 1992-10-09

Similar Documents

Publication Publication Date Title
SE9202968L (sv) Nya peptider, diagnostiska antigener, deras användning, vacciner och medikamenter
DK0610250T3 (da) Vaccine med porcint reproduktivt respiratorisk syndrom og diagnose heraf
NO871313L (no) Fremgangsmaate for fremstilling av virusvaksine.
DE69334192D1 (de) Papillomavirus vakzine
RU93058614A (ru) Мутант вируса герпеса, композиции, диагностические наборы, способы определения инфекции
RU96119986A (ru) Вакцина для предохранения свиньи от респираторных или репродуктивных заболеваний, содержащая парагриппозные вирусы
Lightman et al. Do L3T4+ T cells act as effector cells in protection against influenza virus infection
ES2109189A1 (es) Vectores basados en genomas virales defectivos recombinantes y su empleo en la formulacion de vacunas.
AR004464A1 (es) Un metodo para producir una proteina de capside de papilomavirus
ATE20309T1 (de) Pharmazeutische zubereitung.
MY103575A (en) Cannie coronavirus vaccine
ATE320444T1 (de) Peptide, die die zytotoxische t-lymphozyte antwort gegen hepatitis-b-virus induzieren
CA2066661A1 (en) Viral vaccine conjugates
SG55095A1 (en) Viruses and their use as a vaccine against feline infectious peritonitis virus disease
Rouse et al. Host defense mechanisms against infectious bovine rhinotracheitis virus: II. Inhibition of viral plaque formation by immune peripheral blood lymphocytes
Sjogren et al. Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate
ATE109158T1 (de) Rubella-e1 und c peptide.
Cox The structural proteins of rabies virus
Lublin-Tennenbaum et al. Correlation between cutaneous reaction in vaccinees immunized against smallpox and antibody titer determined by plaque neutralization test and ELISA
Arnon et al. Anti-influenza synthetic vaccine.
SE9202318D0 (sv) Nya peptider, diagnostiska antigen, anvaendning daerav, vacciner och medikamenter
RU93039551A (ru) Способ получения специфической сыворотки для лечения, диагностики и профилактики вирусной геморрагической болезни кроликов и набор для диагностики болезни
Süss et al. The modulation of the specific and non-specific host response in case of influenza virus infection and vaccination in man
Potgieter Pathogenesis of viral infections
Parra et al. IFN-γ Secreted by Virus-Specific CD8+ T Cells Contribute to CNS Viral Clearance

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9202968-5

Effective date: 19941208